EdRIP and Initiative & Finance exit Laboratoires Filorga

Tha value of the management buy-back was not disclosed, but EdRIP's small-cap funds reaped a 3.2x money multiple and 32% IRR on the original investment.

EdRIP and I&F backed the management buy-in of Laboratoires Filorga in 2006. EdRIP provided 60% of the equity, while I&F contributed 40%. The two sponsors took a majority stake, while CEO Didier Tabary took a 15% interest in the business.

Founded in 1978, Laboratoires Filorga has developed a range of anti-ageing products including wrinkle-filling injections, mesotherapy treatments and other dermatological solutions.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Grégoire Gille on +44 20 7484 9824 or gregoire.gille@incisivemedia.com

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Exits
• Healthcare
• Rothschild & Cie
• France
• Management buy-back